Novartis
Report Details
ESG Index: Access to medicines
ESG Index: Access to medicines
Our approach and targets
Improving access to medicines remains one of the world’s greatest healthcare
challenges. At Novartis, we know that building trust with society depends not only on
finding new treatments but also on making them available to as many people as
possible.
Through the Novartis Access Principles, we seek to expand access to our medicines to
underserved patient populations in both developed and developing countries, while
addressing major global...
Our approach and targets
Improving access to medicines remains one of the world’s greatest healthcare
challenges. At Novartis, we know that building trust with society depends not only on
finding new treatments but also on making them available to as many people as
possible.
Through the Novartis Access Principles, we seek to expand access to our medicines to
underserved patient populations in both developed and developing countries, while
addressing major global...
Report Type
Comprehensive Sustainability Report
Language
English
Year
2023
Format
217.97 MB - PDF
Report Standards:
GRI
ISSB
UN SDG
Similar Reports
(Based on specified tags) Industry / Geography
Report Type
|
2024
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
Report Type
|
2025
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.
Report Type
|
2025
Sustainable Living Plan 2025
Our commitment to sustainable business practices and positive social impact across the value chain.